8 ASX 200 shares with renewed buy ratings this week

Brokers retained a positive view on CSL, GQG Partners, ANZ, and other shares this week. 

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX 200 Index (ASX: XJO) shares are down 0.4% to 8,614.8 points on Thursday.

Meanwhile, brokers have indicated continuing confidence in several ASX 200 shares with refreshed buy calls this week.

Here are some examples.

A young woman smiling and looking happy, indicating a positive share price movement on the ASX market.

Image source: Getty Images

CSL Ltd (ASX: CSL)

The CSL share price is $107.34, up 4.3% today.

The ASX 200's largest healthcare share is having a strong week despite no price-sensitive announcements.

Since last Friday's close, CSL shares have spiked 9.6% while the S&P/ASX 200 Health Care Index (ASX: XHJ) has lifted just 3.6%.

CSL shares have fallen 63% over two years, but perhaps a turnaround is afoot?

UBS reiterated its buy rating on CSL shares on Tuesday.

However, the broker lowered its target price from $175 to $158.

This still implies potential capital gains of 47% ahead.

South32 Ltd (ASX: S32)

The South32 share price is $4.35, down 2.9% today.

Over the past six months, this ASX 200 mining share has risen 27%.

Citi reaffirmed its buy rating on South32 shares on Tuesday.

The broker increased its 12-month price target from $5.40 to $6.10.

This suggests a potential 40% upside ahead.

Flight Centre Travel Group Ltd (ASX: FLT)

The Flight Centre share price is $10.97, down 3.1%.

This ASX 200 travel share has fallen 26% over six months.

But UBS is confident of a turnaround, reiterating its buy rating this week.

The broker has a $14.50 target on the ASX 200 consumer discretionary share.

This suggests a 32% upside from here.

ANZ Group Holdings Ltd (ASX: ANZ)

The ANZ share price is $34.02, down 1.6% today.

This ASX 200 bank share has fallen 5.3% over the past month.

Citi reiterated its buy rating on ANZ shares with a price target of $39.25 on Tuesday.

This implies potential capital gains of 15% ahead.

GQG Partners Inc (ASX: GQG)

The GQG Partners share price is $1.46, up 0.3% today.

Over the past six months, this ASX 200 financial share has fallen 17%.

Morgans renewed its accumulate rating on GQG Partners shares yesterday.

The broker lowered its 12-month price target from $2.03 to $1.64.

This suggests a potential 12% upside ahead.

Morgans commented:

While the near-term operating environment remains difficult, we continue to see long-term value in the GQG franchise, trading at ~9x FY1 PE with a ~10% dividend yield.

Life360 Inc (ASX: 360)

The Life360 share price is $21.21, down 1.6% today.

Over the past month, this ASX tech share has recovered 5.6%.

Life360 has lost 33% of its valuation over the past 12 months.

Citi reaffirmed its buy rating on Life360 shares on Tuesday.

The broker modified its target from $32.10 to $28.25, suggesting a potential 33% increase from here.

SRG Global Ltd (ASX: SRG)

The SRG Global share price is $3.69, down 3.5% today.

This ASX 200 industrials share has ascended 32% over six months.

Morgans renewed its buy call on SRG Global shares this week.

The broker also lifted its target price from $3.20 to $4.20.

This implies potential capital growth of 13% over the next year.

Morgans said:

SRG has upgraded FY26 EBITDA guidance to the upper end of its $164-168m range (~$168m) and, unusually early, provided FY27 EBITDA guidance of $190-200m. This underlines the group's strong earnings visibility, which is arguably unparalleled in the services sector.

We forecast SRG reaches net cash in FY26 and, on that basis, expect it to resume acquisitions. We believe SRG may be able to continue to compound +20-30% EPS growth over the next few years as robust organic growth is supplemented by strategic acquisitive growth. 

Centuria Capital Group (ASX: CNI)

The Centuria Capital share price is $2.02, up 2.5% today and down 4.3% over six months.

Centuria Capital Group is a funds manager specialising in property investment and investment bonds.

Morgan Stanley renewed its buy rating on this ASX 200 real estate share on Tuesday.

The broker lifted its 12-month price target from $2.05 to $2.35.

This suggests a potential 16% upside ahead.

Citigroup is an advertising partner of Motley Fool Money. Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL and Life360. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended CSL, Flight Centre Travel Group, Gqg Partners, and Srg Global. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

A young African mine worker is standing with a smile in front of a large haul dump truck wearing his personal protective wear.
Broker Notes

This ASX gold stock could jump by 45%, brokers say

This company has big expansion plans.

Read more »

Engineer looking at mining trucks at a mine site.
Broker Notes

What are the top picks in the ASX lithium sector right now?

A recent pullback in share prices could be creating opportunities.

Read more »

A bland looking man in a brown suit opens his jacket to reveal a red and gold superhero dollar symbol on his chest.
Broker Notes

Macquarie tips three ASX finance companies to return better than 30%

These finance stocks could be worth a look.

Read more »

A miner shakes hands with a businessman or banker inside an underground mine setting.
Broker Notes

A miner and an energy company to buy according to Macquarie

The broker is bullish on these two companies.

Read more »

A businessman holds his hand to his wide-open yawning mouth as he closes his eyes and makes a funny face while he gives a wholehearted yawn.
Broker Notes

How much could ResMed shares rise according to Morgans?

Current share price weakness could be an opportunity.

Read more »

Young successful engineer, with blueprints, notepad, and digital tablet, observing the project implementation on construction site and in mine.
Broker Notes

2 ASX mining project developers which could more than triple in value

These companies are progressing their projects well.

Read more »

A young man goes over his finances and investment portfolio at home.
Broker Notes

Buy, hold, sell: Pro Medicus, Worley, and ResMed shares

Morgans has given its view on these stocks.

Read more »

Worker on a laptop at an oil and gas pipeline.
Broker Notes

Morgans just placed a fresh buy rating on this ASX utilities stock 

This utilities stock appears oversold.

Read more »